Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels

[1]  M. Jabra-Rizk,et al.  Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals. , 2013, Journal of AIDS & clinical research.

[2]  M. Moriyama,et al.  Close association between oral Candida species and oral mucosal disorders in patients with xerostomia. , 2012, Oral diseases.

[3]  S. Chambers,et al.  Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. , 2011, Medical mycology.

[4]  A. Mane,et al.  Adherence to buccal epithelial cells, enzymatic and hemolytic activities of Candida isolates from HIV-infected individuals. , 2010, Medical mycology.

[5]  S. Bembalkar,et al.  Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV infected individuals. , 2010, The Indian journal of medical research.

[6]  S. Talungchit,et al.  Effects of long-term use of HAART on oral health status of HIV-infected subjects. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[7]  J. Selvin,et al.  Phospholipase C, proteinase and hemolytic activities of Candida spp. isolated from pulmonary tuberculosis patients , 2009 .

[8]  N. Cerikcioglu,et al.  Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures , 2007, Mycopathologia.

[9]  L. K. H. Souza,et al.  Asymptomatic oral carriage of Candida species in HIV-infected patients in the highly active antiretroviral therapy era. , 2006, Revista do Instituto de Medicina Tropical de Sao Paulo.

[10]  Dorthea A. Johnson,et al.  Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART). , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[11]  L. McDonald,et al.  Colonization of Human Immunodeficiency Virus-Infected Outpatients in Taiwan with Candida Species , 2005, Journal of Clinical Microbiology.

[12]  Donald R. Miller,et al.  Xerostomic medications and oral health: the Veterans Dental Study (part I). , 2003, Gerodontology.

[13]  R. Mulligan,et al.  A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[14]  A. Fleva,et al.  Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects , 2002, International journal of STD & AIDS.

[15]  R. Swoboda,et al.  A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis. , 2002, The Journal of infectious diseases.

[16]  M. Nucci,et al.  Relationship between salivary flow rates and Candida counts in subjects with xerostomia. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[17]  E. Komaroff,et al.  The Prevalence of Xerostomia and Salivary Gland Hypofunction in a Cohort of HIV-positive and At-risk Women , 2000, Journal of dental research.

[18]  M. Rinaldi,et al.  Further Characterization of Human Salivary Anticandidal Activities in a Human Immunodeficiency Virus-Positive Cohort by Use of Microassays , 1999, Clinical Diagnostic Laboratory Immunology.

[19]  D. Rahman,et al.  IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. , 1995, Immunology.

[20]  C. Barr,et al.  Longitudinal study of parotid saliva in HIV-1 infection. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[21]  J. Koval,et al.  Factors associated with increased frequency of HIV-related oral candidiasis. , 1991, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[22]  S. Frøland,et al.  Both IgA subclasses are reduced in parotid saliva from patients with AIDS , 1991, Clinical and experimental immunology.

[23]  D. Kotler,et al.  Intestinal plasma cell alterations in acquired immunodeficiency syndrome , 1987, Digestive Diseases and Sciences.

[24]  G. Proctor,et al.  A Comparative Study of Salivary Composition of HIV Seropositive Patients on HAART and Not on HAART , 2011 .

[25]  K. Stoltze,et al.  Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[26]  W. Mack,et al.  Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS). , 2009, Oral diseases.

[27]  J. Belforte,et al.  Standardization of a simple method to study whole saliva: clinical use in different pathologies. , 2006, Acta odontologica latinoamericana : AOL.

[28]  S. Michalek,et al.  Advances in Mucosal Immunology , 1995, Advances in Experimental Medicine and Biology.

[29]  T. Soukka,et al.  Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. , 1991, Proceedings of the Finnish Dental Society. Suomen Hammaslaakariseuran toimituksia.

[30]  S. Jackson.  Secretory and serum IgA are inversely altered in AIDS patients , 1990 .